Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and others in the Cambridge-London life sciences corridor, and wider local and international ecosystems.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Coulter Partners places R&D Senior Project Director at Vicore Pharma Holding

LONDON, UK & COPENHAGEN, Denmark – November 4, 2025 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for Vicore Pharma Holding AB (STO: VICO) and is pleased to announce the placement of Katrine Husum as R&D Senior Project Director.

Post Doc - Isidro Cortes-Ciriano Group

Your group

The Cortes-Ciriano group studies the mutational processes and mechanisms of genome instability
underpinning tumourigenesis, immune escape, and drug response through the analysis of high-throughput sequencing data from clinical samples. The group is also leading the development of novel approaches for early cancer detection using long-read sequencing. More information about the group can be found here.

Your supervisor

AI in Lab Procurement: How Automation Is Changing Scientific Supply Chains

Labs using AI in their supply chains are seeing serious gains. Think a 35% reduction in inventory levels, 15% lower logistics costs, and $300 million in savings by predicting stock risks before they happen. The secret? Smart automation.

Artificial intelligence (AI) is transforming how life science labs manage procurement, from forecasting inventory needs to streamlining vendor selection. Tasks that once required hours of manual effort, like comparing prices, coordinating orders, and pulling spend information, can now be done in minutes.

Head of Science & Innovation - COSMIC

Do you want to help us improve human health and understand life on Earth? Make your mark by shaping the future to enable or deliver life-changing science to solve some of humanity’s greatest challenges.

We have an exciting opportunity for a Head of Science and Innovation to help shape the future direction of one of the world’s leading cancer genomics resources. You’ll join a diverse, multidisciplinary team working at the cutting edge of data and discovery where collaboration, innovation, and inclusion is central to everything we do.

Senior Scientist Functional Genomics

At Insmed, every moment and every patient counts — and so does every person who joins in. As a global biopharmaceutical company dedicated to transforming the lives of patients with serious and rare diseases, you’ll be part of a community that prioritizes the human experience, celebrates curiosity, and values every person’s contributions to meaningful progress. That commitment has earned us recognition as Science magazine’s No.

Qureight Vascul8 model for pulmonary vascular disorders validated in peer-reviewed study, offering potential to improve treatment options and patient outcomes following surgery

  • Study published in ‘American Journal of Respiratory Cell and Molecular Biology’ validates Qureight’s deep-learning models and imaging platform beyond fibrotic lung disease, into new therapeutic areas for severe respiratory disease
  • Data demonstrate sensitive quantification of vascular remodelling and prediction of disease severity from routine CT scans, following surgical removal of chronic blood clots

Cost-effective cryopreservation without compromise

A new blog has been published by Amsbio comparing the benefits of its CELLBANKER® range of cryopreservation solutions with ‘homebrew’ cryopreservation media.

Homebrew cryopreservation media are do-it-yourself solutions, commonly using a mixture of DMSO, a serum (such as FBS), and a basal growth medium. These mixtures are often favored because of their lower upfront cost or to meet specific lab needs, but the optimal formulation depends heavily on the cell line's sensitivity.

Translating Breast Cancer Drug Discovery Through Smarter Preclinical Models

Breast cancer continues to affect millions worldwide, not just as statistics, but as mothers, sisters, daughters, and friends. Its biological complexity and diverse subtypes make therapy development especially challenging, particularly for metastatic disease, the leading cause of breast cancer mortality.

BioDuro’s CDX (Cell-Derived Xenograft) model platform offers a comprehensive library of preclinical breast cancer models that reflect real-world tumor heterogeneity. These models enable researchers to:

Subscribe to